SCHEMBL10357705

SCHEMBL10357705

CC(=O)OC(C)OC(=O)N(CC(O)COc1ccc(CCOC2CC2)cc1)C(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.39
ADRB1 P08588 3/20 0.39
LMNA P02545 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
ADRB2 P07550 2/20 0.39
GAA P10253 1/20 0.39
BLM P54132 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
NPY1R P25929 1/20 0.37
NPY2R P49146 1/20 0.37
PMP22 Q01453 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NR3C1 P04150 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10358142 0.80 LMNA (0.53) ABCB1ADRB1LMNACYP1A2ADRB2
Betazolol SCHEMBL29558565 0.77 HIF1A (0.51) ADRB1LMNAMEN1KMT2ACYP2D6
SCHEMBL11875628 0.74 ADRB2 (0.53) ABCB1ADRB1MEN1KMT2ACYP2D6
SCHEMBL16081355 0.70 ADRB1 (0.55) ABCB1ADRB1LMNAMEN1KMT2A
SCHEMBL10358158 0.68 NR2E1 (0.51) ABCB1ADRB1LMNAMEN1KMT2A
SCHEMBL10979711 0.68 ADRB1 (0.70) ADRB1LMNAMEN1KMT2ACYP2D6
SCHEMBL10357692 0.67 HTR1A (0.60) ADRB1LMNAMEN1KMT2ACYP2D6
SCHEMBL10985036 0.67 ADRB1 (0.69) ADRB1LMNAMEN1KMT2ACYP2D6
SCHEMBL16077979 0.67 ADRB1 (0.51) ADRB1LMNAMEN1KMT2ACYP2D6
SCHEMBL21916490 0.66 ADRB1 (0.55) ABCB1ADRB1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0167451-B1 A NEW PROCESS FOR PREPARING NOVEL N-(ACYLOXY-ALKOXY) CARBONYL DERIVATIVES USEFUL AS BIOREVERSIBLE PRODRUG MOIETIES FOR PRIMARY AND SECONDARY AMINE FUNCTIONS IN DRUGS MERCK & CO. INC. (US) 1990-10-03 EP disclosed
US-4916230-A Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs MERCK & CO., INC. (US) 1990-04-10 US disclosed
EP-0167451-A2 A new process for preparing novel N-(acyloxy-alkoxy) carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs MERCK & CO. INC. (US) 1986-01-08 EP disclosed